Key Takeaways
- Canada’s Drug Agency (CDA-AMC) has published a new position statement on the use of artificial intelligence (AI) methods in health technology assessments (HTAs).
Drug companies that are considering using artificial intelligence (AI)-informed evidence in the health technology assessment dossiers they submit in Canada...